CinCor is a clinical stage therapeutics company that specializes in cardiovascular health.
CINC
29.06 as of 2/23/23
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 10/12/2021 | Series B | $370.57MM | $XXX.XX | $XXX.XX |
| 5/14/2019 | Series A | $66.67MM | $XXX.XX | $XXX.XX |
